SERUM INSTITUTE OF INDIA PVT. LTD.
Serum Institute of India Pvt. Ltd. is the vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 140 countries across the globe in their national immunization programs, saving millions of lives throughout the world.
SERUM INSTITUTE OF INDIA PVT. LTD.
Social Links:
Industry:
Health Care Manufacturing Pharmaceutical
Founded:
1996-01-01
Address:
Pune, Maharashtra, India
Country:
India
Website Url:
http://www.seruminstitute.com
Total Employee:
1001+
Status:
Active
Contact:
+912026993900
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Domain Not Resolving Global Site Tag Microsoft Exchange Online
Similar Organizations
Instituto Sanidad Ganadera
Instituto Sanidad Ganadera S.R.L. manufacturers vaccines for cattle.
LeapMed
LeapMed is a manufacturer and supplier of ultrasound biopsy kits.
Olive Lifesciences
Olive Lifesciences is a manufacturer and supplier of botanical extracts and phytochemicals.
Zim Laboratories
Zim Laboratories is a manufacturer of pharmaceutical products.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-04-25 | Nanotherapeutics | Nanotherapeutics acquired by Serum Institute of India Pvt. Ltd. | 72 M EUR |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-09-22 | Oxford BioMedica | Serum Institute of India Pvt. Ltd. investment in Post-IPO Equity - Oxford BioMedica | 50 M GBP |
| 2021-08-17 | Schott Kaisha | Serum Institute of India Pvt. Ltd. investment in Corporate Round - Schott Kaisha | N/A |
| 2019-07-23 | X-Vax Technology | Serum Institute of India Pvt. Ltd. investment in Series A - X-Vax Technology | 56 M USD |
| 2017-10-05 | Visterra | Serum Institute of India Pvt. Ltd. investment in Series C - Visterra | 23.6 M USD |
Official Site Inspections
http://www.seruminstitute.com Semrush global rank: 348.57 K Semrush visits lastest month: 170.49 K
- Host name: cloudproxy10179.sucuri.net
- IP address: 192.124.249.179
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
